Stanford trial seeks to match cancer patients to drugs based on their Tumor's DNA
NCT ID NCT02215928
Summary
This study is testing whether analyzing the genetic makeup of a person's cancer can help doctors recommend more effective, personalized treatments. Researchers will collect tumor samples and blood from 100 adults with advanced cancer that has spread. The main goal is to see if this 'genomic profiling' approach is practical and can identify specific drug targets for individual patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94305, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.